Targovax appoints Damian Marron as chairman
Mr. Marron is an experienced non-executive director, corporate advisor and life science executive with a successful track record of value creation through public and venture capital financing, portfolio planning, M&A, licensing agreements as well as R&D collaborations, both as an executive and in advisory roles.
Mr. Marron has notably specialized in immuno-oncology, cell therapy and orphan diseases.
Mr. Marron is currently Non-Executive Director at Bone Therapeutics a clinical stage, regenerative medicine company listed on Euronext and Resolys Bio, a private, late pre-clinical US startup.
He is also Head of Biopharma with Treehill Partners, a global pure-play healthcare advisory firm. ■